{"id":"NCT01468207","sponsor":"AbbVie (prior sponsor, Abbott)","briefTitle":"Efficacy and Safety Study of Adalimumab in Treatment of Hidradenitis Suppurativa","officialTitle":"A Phase 3 Multicenter Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa - PIONEER I","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-11","primaryCompletion":"2014-01","completion":"2014-01","firstPosted":"2011-11-09","resultsPosted":"2015-10-28","lastUpdate":"2021-07-07"},"enrollment":307,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Hidradenitis Suppurativa (HS)"],"interventions":[{"type":"BIOLOGICAL","name":"adalimumab","otherNames":["Humira"]},{"type":"BIOLOGICAL","name":"placebo","otherNames":[]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Adalimumab Every Week (EW)","type":"EXPERIMENTAL"},{"label":"Placebo/Adalimumab Every Week (EW)","type":"EXPERIMENTAL"},{"label":"Adalimumab Every Week (EW)/Placebo","type":"EXPERIMENTAL"},{"label":"Adalimumab Every Week (EW)/ Adalimumab Every Other Week (EOW)","type":"EXPERIMENTAL"},{"label":"Adalimumab Every Week (EW)/Adalimumab Every Week (EW)","type":"EXPERIMENTAL"}],"summary":"A study to evaluate the safety and efficacy of treatment with adalimumab in adults with moderate to severe hidradenitis suppurativa (HS).","primaryOutcome":{"measure":"Percentage of Participants Achieving Hidradenitis Suppurativa Clinical Response (HiSCR) at Week 12","timeFrame":"Baseline (Week 0) up to Week 12","effectByArm":[{"arm":"Placebo","deltaMin":26,"sd":null},{"arm":"Adalimumab Every Week (EW)","deltaMin":41.8,"sd":null},{"arm":"Placebo - Baseline Hurley Stage II","deltaMin":29.8,"sd":null},{"arm":"Placebo - Baseline Hurley Stage III","deltaMin":21.4,"sd":null},{"arm":"Adalimumab Every Week (EW) - Baseline Hurley Stage II","deltaMin":44.6,"sd":null},{"arm":"Adalimumab Every Week (ew) - Baseline Hurley Stage III","deltaMin":38.6,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"=0.003"},{"comp":"OG002 vs OG004","p":"=0.048"},{"comp":"OG003 vs OG005","p":"=0.027"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":4},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["27518661","39141589","29380251"],"seeAlso":["http://rxabbvie.com"]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":152},"commonTop":["HIDRADENITIS","NASOPHARYNGITIS","HEADACHE","UPPER RESPIRATORY TRACT INFECTION","URINARY TRACT INFECTION"]}}